Literature DB >> 21728062

c-Abl in neurodegenerative disease.

Sarah D Schlatterer1, Christopher M Acker, Peter Davies.   

Abstract

The c-Abl tyrosine kinase participates in a variety of cellular functions, including regulation of the actin cytoskeleton, regulation of the cell cycle, and the apoptotic/cell cycle arrest response to stress, and the Abl family of kinases has been shown to play a crucial role in development of the central nervous system. Recent studies have shown c-Abl activation in human Alzheimer's and Parkinson's diseases and c-Abl activation in mouse models and neuronal culture in response to amyloid beta fibrils and oxidative stress. Overexpression of active c-Abl in adult mouse neurons results in neurodegeneration and neuroinflammation. Based on this evidence, a potential role for c-Abl in the pathogenesis of neurodegenerative disease is discussed, and we attempt to place activation of c-Abl in context with other known contributors to neurodegenerative pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21728062      PMCID: PMC3329755          DOI: 10.1007/s12031-011-9588-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  79 in total

1.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.

Authors:  Z M Yuan; H Shioya; T Ishiko; X Sun; J Gu; Y Y Huang; H Lu; S Kharbanda; R Weichselbaum; D Kufe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

2.  Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease.

Authors:  I Vincent; J H Zheng; D W Dickson; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  1998 Jul-Aug       Impact factor: 4.673

Review 3.  Functional role for the c-Abl protein tyrosine kinase in the cellular response to genotoxic stress.

Authors:  S Kharbanda; Z M Yuan; R Weichselbaum; D Kufe
Journal:  Biochim Biophys Acta       Date:  1997-10-24

4.  Regulation of Rad51 function by c-Abl in response to DNA damage.

Authors:  Z M Yuan; Y Huang; T Ishiko; S Nakada; T Utsugisawa; S Kharbanda; R Wang; P Sung; A Shinohara; R Weichselbaum; D Kufe
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

Review 5.  Inflammatory process in Parkinson's disease: role for cytokines.

Authors:  T Nagatsu; M Sawada
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 6.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

7.  Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells.

Authors:  S Dan; M Naito; H Seimiya; A Kizaki; T Mashima; T Tsuruo
Journal:  Oncogene       Date:  1999-02-11       Impact factor: 9.867

8.  Essential roles for the Abl and Arg tyrosine kinases in neurulation.

Authors:  A J Koleske; A M Gifford; M L Scott; M Nee; R T Bronson; K A Miczek; D Baltimore
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

Review 9.  Determination of cell fate by c-Abl activation in the response to DNA damage.

Authors:  S Kharbanda; Z M Yuan; R Weichselbaum; D Kufe
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

10.  Mitotic mechanisms in Alzheimer's disease?

Authors:  I Vincent; M Rosado; P Davies
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  50 in total

1.  c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.

Authors:  Hui-Yi Kua; Huijuan Liu; Wai Fook Leong; Lili Li; Deyong Jia; Gang Ma; Yuanyu Hu; Xueying Wang; Jenny F L Chau; Ye-Guang Chen; Yuji Mishina; Sharon Boast; James Yeh; Li Xia; Guo-Qiang Chen; Lin He; Stephen P Goff; Baojie Li
Journal:  Nat Cell Biol       Date:  2012-06-24       Impact factor: 28.824

2.  Angiotensin-II and MARCKS: a hydrogen peroxide- and RAC1-dependent signaling pathway in vascular endothelium.

Authors:  Hermann Kalwa; Juliano L Sartoretto; Simone M Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.

Authors:  Jinbo Cheng; Yajin Liao; Lei Xiao; Rong Wu; Siqi Zhao; Hong Chen; Baidong Hou; Xia Zhang; Chengyu Liang; Yun Xu; Zengqiang Yuan
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

4.  Modelling c-Abl Signalling in Activated Neutrophils: the Anti-inflammatory Effect of Seliciclib.

Authors:  Robert C Jackson; Tomas Radivoyevitch
Journal:  Biodiscovery       Date:  2013-03-01

Review 5.  The c-Abl inhibitor in Parkinson disease.

Authors:  Zhi-Hua Zhou; Yun-Fan Wu; Xue-Min Wang; Yong-Zhu Han
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 6.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

Review 7.  Systems biology approaches for discovering biomarkers for traumatic brain injury.

Authors:  Jacob D Feala; Mohamed Diwan M Abdulhameed; Chenggang Yu; Bhaskar Dutta; Xueping Yu; Kara Schmid; Jitendra Dave; Frank Tortella; Jaques Reifman
Journal:  J Neurotrauma       Date:  2013-07-01       Impact factor: 5.269

8.  c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.

Authors:  R Wu; H Chen; J Ma; Q He; Q Huang; Q Liu; M Li; Z Yuan
Journal:  Cell Death Differ       Date:  2015-10-30       Impact factor: 15.828

9.  Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease.

Authors:  Thomas M Kaiser; Zackery W Dentmon; Christopher E Dalloul; Savita K Sharma; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2020-03-12       Impact factor: 4.345

Review 10.  The capable ABL: what is its biological function?

Authors:  Jean Y J Wang
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.